Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
Rhea-AI Summary
Lifeward (Nasdaq: LFWD) has announced a virtual Investor Event scheduled for February 20, 2025, at 10:00 am EST. The event will feature presentations and Q&A sessions with executive leadership focusing on the company's strategy, key initiatives, and financial outlook.
The event will showcase innovative products from Lifeward's portfolio, including the ReWalk Exoskeleton for spinal cord injuries and the AlterG Anti-Gravity System for rehabilitation of orthopedic and neurological conditions. The virtual event will be accessible to investors, analysts, media, and other interested parties through a webcast, with both live access and replay available on the Investor Relations section of the Lifeward website at GoLifeward.com.
Positive
- None.
Negative
- None.
MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it will host a virtual Investor Event on Thursday, February 20, 2025, beginning at 10:00 am EST. The event will feature presentations and question-and-answer sessions by members of the executive leadership team on the Company's strategy, key initiatives, and financial outlook. To register for the webcast, click here.
In addition, the event will highlight innovative products from the Lifeward portfolio, including the ReWalk Exoskeleton, which addresses unmet medical needs for people with spinal cord injuries, and the AlterG Anti-Gravity System, standard of care for rehabilitation of a broad range of orthopedic and neurological conditions.
The Investor Event will be held virtually with a webcast available for investors, analysts, the media, and other interested parties who wish to join. The live webcast and subsequent replay of the event will be available on the Investor Relations section of the Lifeward website at GoLifeward.com.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Lifeward Media Relations:
Kathleen O’Donnell
VP Marketing & New Business Development
Lifeward Ltd.
E: media@golifeward.com
Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward Ltd.
E: ir@golifeward.com
FAQ
When is Lifeward's (LFWD) Virtual Investor Event scheduled for 2025?
What products will be highlighted at Lifeward's (LFWD) 2025 Investor Event?
How can investors access Lifeward's (LFWD) February 2025 Virtual Investor Event?
What topics will be covered at Lifeward's (LFWD) 2025 Investor Event?
What medical conditions do Lifeward's (LFWD) featured products address?
